|Articles|June 20, 2023
End-to-End Oligonucleotide Solutions
Author(s)Agilent
This short video provides an overview of a complete, end-to-end oligonucleotide workflow solutions
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
3
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5